Skip to main content
. 2023 Sep 22;59(10):1699. doi: 10.3390/medicina59101699

Table 1.

Comparison of the patients’ characteristics in non-COVID-19 period patients (years 2019 and 2023) and COVID-19 period patients (years 2020–2022).

Characteristics Period p-Value
Non-COVID-19 COVID-19
Age (years), mean ± SD 38.80 ± 17.71 44.53 ± 13.27 0.078
Gender, n (%) Male 26 (65%) 35 (66.04%) 1.000
Female 14 (35%) 18 (33.96%)
Marital status, n (%) Married 26 (65%) 43 (81.13%) 0.097
Unmarried 14 (35%) 10 (18.87%)
Education, n (%) College 8 (20%) 23 (43.4%) 0.186
High school 10 (25%) 11 (20.75%)
Kindergarten 2 (5%) 0 (0)
Master’s degree 1 (2.5%) 0 (0)
Middle school 8 (20%) 9 (16.98%)
No formal education 8 (20%) 7 (13.21%)
Primary school 3 (7.5%) 3 (5.66%)
Occupation, n (%) Driver 3 (7.5%) 3 (5.66%) 0.293
Farmer 4 (10%) 2 (3.77%)
Government office 7 (17.5%) 9 (16.98%)
Kindergarten student 2 (5%) 0 (0)
Other 7 (17.5%) 8 (15.09%)
Retired 1 (2.5%) 2 (3.77%)
Student 3 (7.5%) 3 (5.66%)
Teacher 1 (2.5%) 10 (18.87%)
Worker 12 (30%) 16 (30.19%)
Ethnicity, n (%) Han 39 (97.5%) 45 (84.91%) 0.051
Miao 0 (0) 2 (3.77%)
Tu Jia 0 (0) 6 (11.32%)
Zhuang 1 (2.5%) 0 (0)
Duration of injury, (Median (IQR)) 12 (2.00%) 12 (12.00%) 0.515
Age at the time of injury 37.93 ± 17.76 43.81 ± 13.43 0.072
Type of damage, n (%) Non-traumatic 9 (22.5%) 18 (33.96%) 0.257
Traumatic 31 (77.5%) 35 (66.04%)
Initial ASIA, n (%) A 10 (25%) 11 (20.75%) 0.517
B 18 (45%) 18 (33.96%)
C 10 (25%) 20 (37.74%)
D 2 (5%) 4 (7.55%)
Level, n (%) Cervical 22 (55%) 16 (30.19%) 0.004
Thoracic 9 (22.5%) 21 (39.62%)
Lumber 8 (20%) 5 (9.43%)
Thoracolumbar 1 (2.5%) 11 (20.75%)
Paralysis type, n (%) Paraplegia 21 (52.5%) 41 (77.36%) 0.015
Tetraplegia 19 (47.5%) 12 (22.64%)
MOI, n (%) Bicycle 1 (2.5%) 1 (1.89%) 0.764
Car 7 (17.5%) 11 (20.75%)
Dance 1 (2.5%) 0 (0)
Disc herniation 0 (0) 1 (1.89%)
Fall 20 (50%) 20 (37.74%)
Motorbike 2 (5%) 3 (5.66%)
Myelopathy/myelitis 4 (10%) 10 (18.86%)
Spinal cord ischemia 1 (2.5%) 3 (5.66%)
Tumor 4 (10%) 4 (7.55%)
Completeness of lesion, n (%) Incomplete 34 (85%) 45 (84.91%)
Complete 6 (15%) 8 (15.09%)
Treatment, n (%) Conservative 6 (15%) 9 (16.98%) 1.000
Surgical 34 (85%) 44 (83.02%)
Final ASIA, n (%) A 5 (12.5%) 5 (9.43%) 0.525
B 7 (17.5%) 15 (28.3%)
C 12 (30%) 9 (16.98%)
D 9 (22.5%) 13 (24.53%)
E 7 (17.5%) 11 (20.75%)